MFEBX
Price
$54.89
Change
-$0.04 (-0.07%)
Updated
Nov 13 closing price
VIVIX
Price
$69.42
Change
+$0.09 (+0.13%)
Updated
Nov 13 closing price
Ad is loading...

MFEBX vs VIVIX

Header iconMFEBX vs VIVIX Comparison
Open Charts MFEBX vs VIVIXBanner chart's image
MFS Value B
Price$54.89
Change-$0.04 (-0.07%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$69.42
Change+$0.09 (+0.13%)
VolumeN/A
CapitalizationN/A
MFEBX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MFEBX vs. VIVIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFEBX is a Buy and VIVIX is a Buy.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. MFEBX (61.5B). VIVIX pays higher dividends than MFEBX: VIVIX (2.37) vs MFEBX (0.66). MFEBX was incepted earlier than VIVIX: MFEBX (27 years) vs VIVIX (26 years). MFEBX is a more actively managed with annual turnover of: 12.00 vs. VIVIX (10.00). MFEBX has a lower initial minimum investment than VIVIX: MFEBX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 29.29 vs. MFEBX (17.26). VIVIX return over 5 years is better than : 53.41 vs. MFEBX (29.87).
MFEBXVIVIXMFEBX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years26 years-
Gain YTD16.91519.00389%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets61.5B184B33%
Annual Yield % from dividends0.662.3728%
Returns for 1 year17.2629.2959%
Returns for 3 years2.0922.519%
Returns for 5 years29.8753.4156%
Returns for 10 years65.81113.8658%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POAI0.810.02
+2.94%
Predictive Oncology
HTGC19.20-0.12
-0.62%
Hercules Capital
SCLX0.74-0.03
-3.80%
Scilex Holding Company
IMOS19.30-0.81
-4.03%
ChipMOS TECHNOLOGIES
SMMT19.47-1.29
-6.21%
Summit Therapeutics